These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38792910)

  • 1. Autoimmune Encephalitis following Checkpoint Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission.
    Civardi G; Medioli A; Braghieri C; Ambroggi M; Immovilli P; Orsucci S; Contini P; Aronica G; Cavanna L
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Epididymo-Orchitis and Encephalitis Complicating Anti-PD-1 Therapy.
    Quach HT; Robbins CJ; Balko JM; Chiu CY; Miller S; Wilson MR; Nelson GE; Johnson DB
    Oncologist; 2019 Jul; 24(7):872-876. PubMed ID: 30936376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis.
    Moradi LA; Clark CA; Schneider CS; Deshane AS; Dobelbower MC
    Front Immunol; 2021; 12():788499. PubMed ID: 34956219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab.
    Shah N; Jacob J; Househ Z; Shiner E; Baird L; Soudy H
    J Immunother Cancer; 2019 Sep; 7(1):247. PubMed ID: 31511075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
    Nakako S; Nakashima Y; Okamura H; Tani Y; Ueda T; Makuuchi Y; Kuno M; Takakuwa T; Nishimoto M; Koh H; Nakamae H; Hino M
    Immunotherapy; 2022 Feb; 14(2):101-105. PubMed ID: 34758635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.
    Williams TJ; Benavides DR; Patrice KA; Dalmau JO; de Ávila AL; Le DT; Lipson EJ; Probasco JC; Mowry EM
    JAMA Neurol; 2016 Aug; 73(8):928-33. PubMed ID: 27271951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.
    Velasco R; Villagrán M; Jové M; Simó M; Vilariño N; Alemany M; Palmero R; Martínez-Villacampa MM; Nadal E; Bruna J
    JAMA Neurol; 2021 Jul; 78(7):864-873. PubMed ID: 33720308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
    Hines J; Daily E; Pham AK; Shea CR; Nadeem U; Husain AN; Stadler WM; Reid P
    J Med Case Rep; 2021 Mar; 15(1):124. PubMed ID: 33736690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of repetitive seizures following immune checkpoint inhibitor therapy as a feature of autoimmune encephalitis.
    Takebayashi Y; Neshige S; Hayashi T; Aoki S; Ueno H; Iida K; Maruyama H
    Epileptic Disord; 2021 Oct; 23(5):733-738. PubMed ID: 34519645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma.
    Bossart S; Thurneysen S; Rushing E; Frontzek K; Leske H; Mihic-Probst D; Nagel HW; Mangana J; Goldinger SM; Dummer R
    Oncologist; 2017 Jun; 22(6):749-753. PubMed ID: 28559410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitor-induced autoimmune encephalitis in metastatic squamous cell lung cancer.
    Wang J; Zheng Q; Chen J
    Immunotherapy; 2023 Apr; 15(6):409-416. PubMed ID: 36950965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature.
    Gao Y; Pan J; Shen D; Peng L; Mao Z; Wang C; Meng H; Zhou Q; Chen S
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab.
    Kethireddy N; Thomas S; Bindal P; Shukla P; Hegde U
    J Oncol Pharm Pract; 2021 Jan; 27(1):207-211. PubMed ID: 32390537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limbic encephalitis following immunotherapy against metastatic malignant melanoma.
    Salam S; Lavin T; Turan A
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27009198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With Melanoma.
    Martínez-Vila C; Laguna JC; Segui E; Ruiz G; Aya Moreno F; Fernandez-Morales LM; Giner Joaquim J; Padrosa J; Fernandez L; Gaba L; Victoria I; Arance Fernandez AM
    J Immunother; 2021 Jun; 44(5):204-207. PubMed ID: 33950029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of Guillain-Barré syndrome-like acute inflammatory demyelinating polyneuropathy caused by pembrolizumab with a combination of corticosteroid and immunoglobulins: a case report].
    Hashimoto R; Ueda T; Tsuji Y; Otsuka Y; Sekiguchi K; Matsumoto R
    Rinsho Shinkeigaku; 2020 Nov; 60(11):773-777. PubMed ID: 33115993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment.
    Bir Yucel K; Sutcuoglu O; Yazıcı O; Yıldız Y; Şenol E; Uner A
    J Oncol Pharm Pract; 2023 Apr; 29(3):760-763. PubMed ID: 35938177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute interstitial nephritis and PR3-ANCA following reintroduction of pembrolizumab: a case report.
    Mulroy M; Ghafouri S; Sisk A; Ribas A; Goshtaseb R; Cherry G; Shen J
    Immunotherapy; 2021 Mar; 13(4):283-288. PubMed ID: 33397120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.